Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 5
2018 18
2019 17
2020 14
2021 15
2022 24
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group. Ramos-Casals M, et al. Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31. Ann Rheum Dis. 2020. PMID: 31672775
Ustekinumab in enteropathic arthritis.
Ulusoy BÖ, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Ulusoy BÖ, et al. Among authors: armagan b. Immunotherapy. 2023 Jun;15(8):583-592. doi: 10.2217/imt-2022-0197. Epub 2023 Apr 5. Immunotherapy. 2023. PMID: 37020400
Tofacitinib experience in patients with enteropathic arthritis.
Dağlı PA, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Dağlı PA, et al. Among authors: armagan b. Immunotherapy. 2023 Jun;15(8):619-626. doi: 10.2217/imt-2022-0110. Epub 2023 Apr 3. Immunotherapy. 2023. PMID: 37009645 Review.
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.
Brito-Zerón P, Flores-Chávez A, Horváth IF, Rasmussen A, Li X, Olsson P, Vissink A, Priori R, Armagan B, Hernandez-Molina G, Praprotnik S, Quartuccio L, Inanç N, Özkızıltaş B, Bartoloni E, Sebastian A, Romão VC, Solans R, Pasoto SG, Rischmueller M, Galisteo C, Suzuki Y, Trevisani VFM, Fugmann C, González-García A, Carubbi F, Jurcut C, Shimizu T, Retamozo S, Atzeni F, Hofauer B, Melchor-Díaz S, Gheita T, López-Dupla M, Fonseca-Aizpuru E, Giacomelli R, Vázquez M, Consani S, Akasbi M, Nakamura H, Szántó A, Farris AD, Wang L, Mandl T, Gattamelata A, Kilic L, Pirkmajer KP, Abacar K, Tufan A, de Vita S, Bootsma H, Ramos-Casals M; Sjögren Big Data Consortium. Brito-Zerón P, et al. Among authors: armagan b. EClinicalMedicine. 2023 Jul 4;61:102062. doi: 10.1016/j.eclinm.2023.102062. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37457113 Free PMC article.
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.
Karadag O, Bolek EC, Ayan G, Mohammad AJ, Grayson PC, Pagnoux C, Martín-Nares E, Monti S, Abe Y, Alberici F, Alibaz-Oner F, Cuthbertson D, Dagna L, Direskeneli H, Khalidi NA, Koening C, Langford CA, McAlear CA, Monach PA, Moroni L, Padoan R, Seo P, Warrington KJ, Hocevar A, Hinojosa-Azaola A, Furuta S, Emmi G, Ozen S, Jayne D, Merkel PA; GLOBAL-PAN Collaborators. Karadag O, et al. Arthritis Rheumatol. 2024 Feb 12. doi: 10.1002/art.42817. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38343337
Some concerns and improvements from Turkey.
Cinar OE, Erden A, Sari A, Armagan B, Kilic L. Cinar OE, et al. Among authors: armagan b. Ann Rheum Dis. 2018 Jun;77(6):e28. doi: 10.1136/annrheumdis-2017-211963. Epub 2017 Aug 10. Ann Rheum Dis. 2018. PMID: 28798052 No abstract available.
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G, Kostov B, Brito-Zerón P, Vissink A, Mandl T, Hinrichs AC, Quartuccio L, Baldini C, Seror R, Szántó A, Isenberg D, Gerli R, Nordmark G, Rasmussen A, Solans-Laque R, Hofauer B, Sène D, Pasoto SG, Rischmueller M, Praprotnik S, Gheita TA, Danda D, Armağan B, Suzuki Y, Valim V, Devauchelle-Pensec V, Retamozo S, Kvarnstrom M, Sebastian A, Atzeni F, Giacomelli R, Carsons SE, Kwok SK, Nakamura H, Fernandes Moça Trevisani V, Flores-Chávez A, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium. Hernández-Molina G, et al. Among authors: armagan b. Rheumatology (Oxford). 2022 Dec 23;62(1):243-255. doi: 10.1093/rheumatology/keac205. Rheumatology (Oxford). 2022. PMID: 35385104
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis.
Brito-Zerón P, Flores-Chávez A, Ng WF, Fanny Horváth I, Rasmussen A, Priori R, Baldini C, Armagan B, Özkiziltaş B, Praprotnik S, Suzuki Y, Quartuccio L, Hernandez-Molina G, Abacar K, Bartoloni E, Rischmueller M, Reis-de Oliveira F, Fernandes Moça Trevisani V, Jurcut C, Fugmann C, Carubbi F, Hofauer B, Valim V, Pasoto SG, Retamozo S, Atzeni F, Fonseca-Aizpuru E, López-Dupla M, Giacomelli R, Nakamura H, Akasbi M, Thompson K, Szántó A, Farris AD, Villa M, Bombardieri S, Kilic L, Tufan A, Perdan Pirkmajer K, Fujisawa Y, de Vita S, Inanc N, Ramos-Casals M; Sjögren Big Data Consortium. Brito-Zerón P, et al. Among authors: armagan b. Clin Exp Rheumatol. 2023 Dec;41(12):2448-2457. doi: 10.55563/clinexprheumatol/p1r1j4. Epub 2023 Nov 29. Clin Exp Rheumatol. 2023. PMID: 38019154 Free article.
103 results